OFG Bancorp Quarterly Cash Flow Statements Chart
Quarterly
|
Annual
OFG Bancorp Quarterly Cash Flow Statements Table
Quarterly
|
Annual
Unit: USD | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 | 2012-03-31 | 2011-03-31 | 2010-03-31 | 2009-03-31 | 2008-03-31 | 2007-03-31 | 2006-03-31 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
cash flows from operating activities: | ||||||||||||
net income | 45,572,000 | 49,692,000 | 46,229,000 | 37,521,000 | 30,373,000 | 10,653,000 | 3,081,000 | 11,936,000 | 24,748,000 | 16,848,000 | 10,991,000 | 8,050,000 |
adjustments to reconcile net income to net cash from operating activities: | ||||||||||||
amortization of premiums, net of accretion of fair value | ||||||||||||
accretion of investment securities discounts, net of amortization of premiums | -83,000 | |||||||||||
amortization of other intangible assets | 1,232,000 | 1,478,000 | 1,725,000 | 2,146,000 | 2,451,000 | |||||||
net change in operating leases | -59,000 | 59,000 | 86,000 | 59,000 | 120,000 | |||||||
depreciation and amortization of premises and equipment | 5,085,000 | 5,286,000 | 5,043,000 | 3,780,000 | 3,366,000 | 1,210,000 | 1,468,000 | 1,333,000 | 1,468,000 | 1,275,000 | 1,393,000 | 1,567,000 |
deferred income tax (benefit) expense | -2,821,000 | |||||||||||
benefit from credit losses | 25,688,000 | 15,121,000 | 9,445,000 | 1,551,000 | 6,324,000 | |||||||
stock-based compensation | 1,615,000 | 1,165,000 | 965,000 | 973,000 | 2,209,000 | 366,000 | 368,000 | 263,000 | 159,000 | 73,000 | 4,000 | 6,000 |
(gain) loss on: | ||||||||||||
sale of securities | 7,000 | -7,360,000 | 2,000 | -12,020,000 | ||||||||
sale of loans | -625,000 | -335,000 | -252,000 | -899,000 | -1,894,000 | |||||||
foreclosed real estate and other repossessed assets | -39,000 | -566,000 | -238,000 | -4,157,000 | -1,583,000 | |||||||
sale of other assets | -1,000 | -20,000 | 6,000 | -181,000 | ||||||||
originations and purchases of loans held-for-sale | -30,040,000 | -27,696,000 | -27,509,000 | -56,954,000 | -92,264,000 | -43,144,000 | -52,807,000 | -49,958,000 | -57,553,000 | -28,142,000 | ||
proceeds from sale of loans held-for-sale | 12,049,000 | 19,685,000 | 3,260,000 | 57,261,000 | 62,886,000 | 22,906,000 | 17,970,000 | 17,633,000 | 22,980,000 | 7,293,000 | 5,227,000 | 6,656,000 |
net increase in: | ||||||||||||
accrued interest receivable | 1,678,000 | -694,000 | 307,000 | 478,000 | 4,519,000 | 1,432,000 | 112,000 | -3,444,000 | 5,329,000 | 15,289,000 | -2,542,000 | -472,000 |
servicing assets | 1,197,000 | -33,000 | 1,576,000 | -473,000 | -616,000 | |||||||
other assets | 9,855,000 | -558,000 | -9,764,000 | 11,298,000 | -7,190,000 | 3,858,000 | 2,374,000 | 419,000 | -6,891,000 | -5,364,000 | -3,239,000 | 152,000 |
accrued interest on deposits and borrowings | -694,000 | -1,254,000 | 543,000 | -152,000 | -291,000 | -627,000 | -312,000 | -563,000 | -2,071,000 | -729,000 | -2,683,000 | -153,000 |
accrued expenses and other liabilities | 13,700,000 | -1,420,000 | 7,259,000 | -28,860,000 | 18,887,000 | -7,409,000 | -17,143,000 | 4,476,000 | ||||
net cash from operating activities | 83,071,000 | 60,991,000 | 52,200,000 | 39,203,000 | 36,404,000 | 6,148,000 | -31,419,000 | -13,906,000 | -20,513,000 | 4,794,000 | -35,255,000 | -335,000 |
see notes to unaudited consolidated financial statements. | ||||||||||||
ofg bancorpunaudited consolidated statements of cash flowsfor the six-month periods ended june 30, 2025 and 2024 | ||||||||||||
cash flows from investing activities: | ||||||||||||
purchases of: | ||||||||||||
investment securities available-for-sale | -99,872,000 | -933,000 | -476,000 | -399,025,000 | -25,894,000 | -77,910,000 | -222,947,000 | -2,104,008,000 | -2,341,384,000 | -2,389,555,000 | -900,000,000 | -101,616,000 |
fhlb stock | -20,700,000 | -12,600,000 | -9,000,000 | 20,000 | 45,000 | -13,199,000 | -4,835,000 | -590,000 | 599,000 | |||
equity securities | -414,000 | -1,693,000 | -573,000 | -998,000 | ||||||||
maturities and redemptions of: | ||||||||||||
investment securities held-to-maturity | 5,196,000 | 4,838,000 | 4,492,000 | -126,777,000 | -119,025,000 | -209,112,000 | 215,533,000 | 63,663,000 | ||||
proceeds from sales of: | ||||||||||||
foreclosed real estate and other repossessed assets, including write-offs | 13,238,000 | 10,363,000 | 15,110,000 | 13,090,000 | 10,159,000 | |||||||
premises and equipment | 1,000 | 20,000 | 580,000 | 101,000 | -26,000 | -75,000 | 5,000 | 14,000 | ||||
origination and purchase of loans, excluding loans held-for-sale | -865,991,000 | -683,420,000 | -631,471,000 | -770,935,000 | -435,363,000 | -67,024,000 | -25,155,000 | -28,153,000 | -29,726,000 | -38,097,000 | -35,515,000 | -79,416,000 |
principal repayment of loans | 768,104,000 | 634,989,000 | 593,606,000 | 612,039,000 | 470,510,000 | 54,868,000 | 30,642,000 | 39,158,000 | 43,563,000 | 44,347,000 | ||
additions to premises and equipment | -4,350,000 | -6,186,000 | -3,118,000 | -9,072,000 | -3,564,000 | -431,000 | -861,000 | -40,000 | -1,829,000 | -1,098,000 | -1,093,000 | -2,046,000 |
net cash from investing activities | -97,319,000 | 163,518,000 | 70,122,000 | -525,171,000 | -86,681,000 | 78,223,000 | 8,907,000 | 54,548,000 | 126,511,000 | -231,382,000 | -781,756,000 | -44,734,000 |
cash flows from financing activities: | ||||||||||||
deposits | 317,026,000 | -205,733,000 | -10,417,000 | 394,932,000 | -124,230,000 | -89,422,000 | 69,377,000 | 30,317,000 | 202,613,000 | 104,304,000 | -25,715,000 | |
securities sold under agreements to repurchase | -75,000,000 | -13,388,000 | 759,788,000 | 85,391,000 | ||||||||
fhlb advances and other borrowings | -70,000,000 | -2,000 | ||||||||||
exercise of stock options and restricted units lapsed, net of employee award repurchased | ||||||||||||
purchase of treasury stock | -23,392,000 | -2,894,000 | -33,479,000 | -7,022,000 | -12,530,000 | -181,000 | -235,000 | |||||
dividends paid on common stock | -11,453,000 | -10,385,000 | -9,572,000 | -6,003,000 | -2,442,000 | -2,269,000 | ||||||
net cash from financing activities | 133,711,000 | -218,290,000 | 174,708,000 | 318,047,000 | -235,851,000 | -109,023,000 | 150,316,000 | 121,380,000 | 187,657,000 | 847,354,000 | 51,315,000 | |
net change in cash and cash equivalents | 119,463,000 | -151,480,000 | -131,535,000 | 190,958,000 | 30,343,000 | 6,246,000 | ||||||
cash and cash equivalents at beginning of period | 591,137,000 | 605,477,000 | 448,946,000 | 277,123,000 | 34,070,000 | 17,269,000 | ||||||
cash and cash equivalents at end of period | 710,600,000 | 453,997,000 | 317,411,000 | 468,081,000 | 64,413,000 | 23,515,000 | ||||||
accretion of fair value | -239,000 | |||||||||||
net decrease (increase) in: | ||||||||||||
ofg bancorpunaudited consolidated statements of cash flowsfor the quarters ended march 31, 2025 and 2024 | ||||||||||||
exercise of stock options and restricted units lapsed | -3,470,000 | -2,170,000 | -1,738,000 | |||||||||
amortization of deferred loan origination fees, net of costs, and fair value premiums on loans | ||||||||||||
deferred income tax expense | 3,808,000 | 15,391,000 | 15,789,000 | 8,451,000 | -3,979,000 | 862,000 | -1,045,000 | |||||
early extinguishment of debt | -42,000 | |||||||||||
the accompanying notes are an integral part of these consolidated financial statements | ||||||||||||
ofg bancorp consolidated statements of cash flowsfor the years ended december 31, 2024, 2023 and 2022 | ||||||||||||
mortgage servicing rights | ||||||||||||
subordinated capital notes | -36,041,000 | |||||||||||
cash and cash equivalents at beginning of year | ||||||||||||
cash and cash equivalents at end of year | ||||||||||||
amortization of investment securities discounts, net of accretion of premiums | ||||||||||||
ofg bancorp unaudited consolidated statements of cash flowsfor the nine-month periods ended september 30, 2024 and 2023 | ||||||||||||
ofg bancorp unaudited consolidated statements of cash flowsfor the six-month periods ended june 30, 2024 and 2023 | ||||||||||||
amortization of deferred loan origination fees and fair value premiums on loans | 827,000 | |||||||||||
amortization of investment securities (discounts), net of accretion of premiums | -3,580,000 | |||||||||||
ofg bancorp unaudited consolidated statements of cash flowsfor the quarters ended march 31, 2024 and 2023 | ||||||||||||
net change in cash, cash equivalents and restricted cash | 6,219,000 | 297,030,000 | -167,921,000 | |||||||||
cash, cash equivalents and restricted cash at beginning of period | 748,173,000 | 550,464,000 | 2,023,650,000 | |||||||||
cash, cash equivalents and restricted cash at end of period | 754,392,000 | 847,494,000 | 1,855,729,000 | |||||||||
ofg bancorp consolidated statements of cash flowsfor the years ended december 31, 2023, 2022 and 2021 | ||||||||||||
loans held for investment | ||||||||||||
redemption of preferred stock | ||||||||||||
dividends paid on preferred stock | -1,201,000 | -1,201,000 | ||||||||||
net cash from (used in ) financing activities | ||||||||||||
cash, cash equivalents and restricted cash at beginning of year | ||||||||||||
cash, cash equivalents and restricted cash at end of year | ||||||||||||
ofg bancorpunaudited consolidated statements of cash flowsfor the nine-month period ended september 30, 2023 and 2022 | ||||||||||||
amortization of deferred loan origination fees (costs) and fair value premiums (discounts) on loans | ||||||||||||
ofg bancorpunaudited consolidated statements of cash flowsfor the six month periods ended june 30, 2023 and 2022 | ||||||||||||
fhlb advances, federal funds purchased, and other borrowings | 199,329,000 | -458,000 | ||||||||||
amortization of deferred loan origination fees and fair value premiums (discounts) on loans | 497,000 | |||||||||||
amortization of investment securities premiums, net of accretion of | -2,343,000 | |||||||||||
ofg bancorpunaudited consolidated statements of cash flowsfor the quarters ended march 31, 2023 and 2022 | ||||||||||||
amortization of deferred loan origination fees and fair value (discounts) premiums on loans | -723,000 | 51,000 | ||||||||||
amortization of fair value premiums on acquired deposits | ||||||||||||
bargain purchase from scotiabank pr & usvi acquisition | ||||||||||||
gain on: | ||||||||||||
ofg bancorpconsolidated statements of cash flowsfor the years ended december 31, 2022, 2021 and 2020 | ||||||||||||
outlays for business acquisitions | ||||||||||||
amortization of investment securities premiums, net of accretion of discounts | 599,000 | 787,000 | 11,841,000 | |||||||||
benefit from (recapture of) credit losses | ||||||||||||
valuation of loans held for sale | ||||||||||||
trading securities | 2,000 | -1,000 | -184,000 | -114,000 | 230,000 | -352,000 | 1,029,000 | -218,000 | -174,000 | |||
see notes to unaudited consolidated financial statements | ||||||||||||
ofg bancorpunaudited consolidated statements of cash flowsfor the nine-month period ended september 30, 2022 and 2021 | ||||||||||||
exercise of stock options with treasury shares | -904,000 | |||||||||||
reconciliation of the consolidated statements of cash flows to the consolidated statements of financial condition: | ||||||||||||
cash and due from banks | 1,849,906,000 | 13,227,000 | ||||||||||
money market investments | 5,648,000 | 10,288,000 | ||||||||||
restricted cash | 175,000 | |||||||||||
total cash, cash equivalents, restricted cash and restricted cash equivalents at end of period | 1,855,729,000 | |||||||||||
ofg bancorpunaudited consolidated statements of cash flowsfor the six-month periods ended june 30, 2022 and 2021 | ||||||||||||
ofg bancorpunaudited consolidated statements of cash flowsfor the quarters ended march 31, 2022 and 2021 | ||||||||||||
deferred income tax benefit | -157,000 | -53,000 | ||||||||||
ofg bancorp consolidated statements of cash flows for the years ended december 31, 2020, 2019 and 2018 | ||||||||||||
fully charged-off loans | ||||||||||||
cash and cash equivalents received in scotiabank acquisition | ||||||||||||
bargain purchase from scotiabank acquisition | ||||||||||||
other investments | -1,595,000 | -31,000 | ||||||||||
cash and cash equivalents received in scotiabank pr & usvi acquisition | ||||||||||||
amortization of core deposit, customer relationships and other intangibles | ||||||||||||
loans held-for-investment | ||||||||||||
derivatives | 1,000 | 3,968,000 | 10,636,000 | -434,000 | 7,803,000 | -9,052,000 | -882,000 | |||||
amortization of deferred loan origination fees and fair value premiums on acquired loans | ||||||||||||
amortization of core deposit and customer relationship intangibles | ||||||||||||
benefit from loan losses | 4,014,000 | 3,200,000 | 1,650,000 | 1,075,000 | 1,001,000 | |||||||
stock-based compensation excess tax benefit recognized in income | ||||||||||||
early extinguishment of repurchase agreements | ||||||||||||
originations of loans held-for-sale | -36,766,000 | -13,243,000 | ||||||||||
sale of other repossessed assets | ||||||||||||
net (decrease) in: | ||||||||||||
fdic shared-loss (benefit) expense | ||||||||||||
benefit from loan and lease losses | 4,349,000 | |||||||||||
sale of other repossesed assets | ||||||||||||
repayments to fdic on shared-loss agreements | ||||||||||||
net change in restricted cash | ||||||||||||
fdic shared-loss benefit | ||||||||||||
sale of mortgage loans held-for-sale | ||||||||||||
foreclosed real estate | 398,000 | 2,397,000 | 2,228,000 | 2,728,000 | 969,000 | 820,000 | 1,218,000 | |||||
proceeds from sale of mortgage loans held-for-sale | ||||||||||||
amortization of deferred loan origination fees, net of costs | 142,000 | 10,000 | 135,000 | 51,000 | -100,000 | -285,000 | -401,000 | |||||
amortization of fair value premiums, net of discounts, on acquired loans | ||||||||||||
other-than-temporary impairment on securities | ||||||||||||
sale of premises and equipment | -82,000 | 8,000 | -14,000 | 1,000 | ||||||||
principal repayment of loans, including covered loans | 58,969,000 | |||||||||||
(repayments to) reimbursements from the fdic on shared-loss agreements | ||||||||||||
equity in undistributed earnings from banking subsidiary | ||||||||||||
equity in undistributed earnings from nonbanking subsidiaries | ||||||||||||
other impairments on securities | 4,000 | |||||||||||
deferred income tax | ||||||||||||
net decrease in other assets | ||||||||||||
net (decrease) in accrued expenses, other liabilities, and dividend payable | ||||||||||||
dividends from banking subsidiary | ||||||||||||
dividends from non-banking subsidiary | ||||||||||||
maturities and redemptions of investment securities available-for-sale | ||||||||||||
net increase in due from bank subsidiary | ||||||||||||
capital contribution to banking subsidiary | ||||||||||||
capital contribution to non-banking subsidiary | ||||||||||||
proceeds from (payments to) exercise of stock options and lapsed restricted units | ||||||||||||
proceeds from issuance of common stock | ||||||||||||
proceeds from issuance of preferred stock | ||||||||||||
dividends paid | -4,645,000 | |||||||||||
fdic shared-loss expense | ||||||||||||
other | ||||||||||||
amortization of prepaid fdic assessment | ||||||||||||
benefit from covered and non-covered loan and lease losses | 10,157,000 | |||||||||||
purchases of swap options | ||||||||||||
reimbursements from the fdic on shared-loss agreements | 24,068,000 | |||||||||||
net change in securities purchased under agreements to resell | -170,000,000 | |||||||||||
cash and cash equivalents received in bbvapr acquisition | ||||||||||||
amortization of fair value discounts on acquired loans | ||||||||||||
other-than-temporary impairments on securities | 632,000 | |||||||||||
deferred income taxes | -1,274,000 | -109,000 | ||||||||||
swaps options | ||||||||||||
equity options | -525,000 | -524,000 | -790,000 | -484,000 | -5,764,000 | |||||||
cash consideration paid for bbvapr acquisition | ||||||||||||
short term borrowings | 3,644,000 | -10,135,000 | -490,237,000 | |||||||||
fhlb advances | ||||||||||||
fdic-guaranteed term notes | -105,000,000 | |||||||||||
issuance of common stock costs | ||||||||||||
issuance of preferred stock costs | ||||||||||||
termination of derivative instruments | 9,000 | 6,534,000 | -236,000 | |||||||||
supplemental cash flow disclosure and schedule of non-cash activities: | ||||||||||||
interest paid | 31,683,000 | 41,445,000 | 55,337,000 | 57,921,000 | 45,828,000 | 40,627,000 | ||||||
income taxes paid | ||||||||||||
mortgage loans securitized into mortgage-backed securities | 16,619,000 | 32,873,000 | 33,355,000 | 12,246,000 | 2,936,000 | |||||||
transfer from loans to foreclosed real estate and other repossessed assets | ||||||||||||
reclassification of loans held-for-investment portfolio to held-for-sale portfolio | ||||||||||||
investment securities held-to-maturity transferred to available-for-sale | ||||||||||||
for the year ended december 31, 2012, the changes in operating assets and liabilities included in the reconciliation of net income to net cash from operating activities, as well as the changes in assets and liabilities presented in the investing and financing sections are net of the effect of the assets acquired and liabilities assumed from the bbvapr acquisition. refer to note 2 to the consolidated financial statements for the composition and balances of the assets and liabilities recorded at fair value by the company on december 18, 2012. the cash received in the transaction, which amounted to 394.6 million, is presented in the investing activities section of the consolidated statements of cash flows as “cash and cash equivalents received in bbvapr acquisition”. | ||||||||||||
the accompanying notes are an integral part of these consolidated financial statements. | ||||||||||||
net amortization (accretion) of fdic shared-loss indemnification asset | 4,827,000 | |||||||||||
other- than- temporary impairments on securities | ||||||||||||
sale of mortgage loans held for sale | -1,330,000 | -799,000 | -862,000 | |||||||||
swap options | ||||||||||||
other repossessed assets | 994,000 | 589,000 | ||||||||||
cash and cash equivalents received in fdic-assisted acquisition | ||||||||||||
exercise of stock options | 391,000 | 2,085,000 | 219,000 | 136,000 | ||||||||
issuance of common stock | 94,574,000 | |||||||||||
issuance of preferred stock | ||||||||||||
repayments of purchase money note issued to the fdic | ||||||||||||
transfer from loans to foreclosed real estate | 4,143,000 | 2,916,000 | 3,409,000 | 1,131,000 | 1,239,000 | 624,000 | ||||||
conversion of preferred stock to common stock | ||||||||||||
for the year ended december 31, 2012, the changes in operating assets and liabilities included in the reconciliation of net income to net cash from operating activities, as well as the changes in assets and liabilities presented in the investing and financing sections are net of the effect of the assets acquired and liabilities assumed from the bbvapr acquisition. refer to note 2 to the consolidated financial statements for the composition and balances of the assets and liabilities recorded at fair value by the group on december 18, 2012. the cash received in the transaction, which amounted to 394.6 million, is presented in the investing activities section of the consolidated statements of cash flows as “cash and cash equivalents received in bbvapr acquisition”. | ||||||||||||
amortization of core deposit intangible | 36,000 | 36,000 | ||||||||||
fair value adjustment of servicing asset | -271,000 | -440,000 | -449,000 | |||||||||
sale of other repossessed properties | -2,000 | |||||||||||
issuance of fdic-guaranteed term notes | ||||||||||||
advances from fhlb | 760,680,000 | 248,150,000 | 1,121,320,000 | 515,195,000 | ||||||||
capital contribution | ||||||||||||
repayments of advances from fhlb | -787,380,000 | -248,150,000 | -1,108,220,000 | -528,495,000 | ||||||||
amortization of premiums, net of accretion of discounts | 7,638,000 | 5,559,000 | 740,000 | -256,000 | 986,000 | |||||||
net amortization (accretion) of fdic loss-share indemnification asset | ||||||||||||
benefit from covered and non covered loan and lease losses | ||||||||||||
early extinguishment of repurchase agreement | ||||||||||||
sale of foreclosed real estate | 132,000 | 117,000 | 162,000 | 250,000 | -37,000 | -104,000 | ||||||
securities purchased under agreements to resell | ||||||||||||
repayments from purchase money note issued to the fdic | ||||||||||||
accretion of fdic loss-share indemnification asset | -1,211,000 | |||||||||||
derivative activities | ||||||||||||
accrued interest payable on deposits and borrowings | ||||||||||||
reimbursements from the fdic on shared loss agreements | ||||||||||||
securities sold under agreements ro repurchase | ||||||||||||
proceeds from: | ||||||||||||
repayments and advances from purchase money note issued to the fdic | ||||||||||||
shared-loss agreements reimbursements from the fdic | 39,839,000 | |||||||||||
mortgage tax credits | ||||||||||||
principal repayments of loans, including covered loans | ||||||||||||
repayments of note payable to the fdic | ||||||||||||
amortization of accretable yield on loans covered by fdic shared-loss agreements | ||||||||||||
bargain purchase gain from fdic assisted acquisition | ||||||||||||
cash and cash equivalents received in fdic-assisted transaction | ||||||||||||
repayments of advances from note payable to the fdic | ||||||||||||
amortization of core deposit intangible assets | ||||||||||||
federal funds purchased and other short term borrowings | -11,226,000 | |||||||||||
repayments of advances from purchase money note issued to the fdic | ||||||||||||
dividends paid on common and preferred stock | -2,173,000 | -2,173,000 | ||||||||||
supplemental cash flow disclosure and schedule of noncash activities: | ||||||||||||
securities sold but not yet delivered | 116,747,000 | 289,565,000 | 26,995,000 | 74,289,000 | 1,192,000 | |||||||
securities purchased but not yet received | 171,813,000 | 112,628,000 | 101,375,000 | |||||||||
common stock used to match defined contribution plan 1165 | 126,000 | 74,000 | 108,000 | |||||||||
servicing asset capitalized | ||||||||||||
sale of securities available-for-sale | -10,340,000 | -9,297,000 | -358,000 | -19,000 | ||||||||
principal repayments of loans | 30,980,000 | |||||||||||
net change in cash and due from banks | 227,378,000 | -38,931,000 | ||||||||||
cash and due from banks at beginning of period | 66,372,000 | 88,983,000 | ||||||||||
cash and due from banks at end of period | 293,750,000 | 50,052,000 | ||||||||||
income tax paid | ||||||||||||
level 1 — | ||||||||||||
credit-related other-than-temporary impairments on securities | ||||||||||||
sale of mortgage loans | ||||||||||||
other liabilities | -544,000 | -1,740,000 | -636,000 | -175,000 | ||||||||
issuance of fdic-guaranted term notes | 105,000,000 | |||||||||||
• | ||||||||||||
mortgage banking activities | -2,153,000 | -1,006,000 | -62,000 | -436,000 | ||||||||
net decrease in: | ||||||||||||
loans receivable | 15,138,000 | |||||||||||
federal funds purchased | 15,117,000 | 9,057,000 | -10,429,000 | 499,593,000 | ||||||||
termination of derivative instrument | -7,875,000 | |||||||||||
level 1- | ||||||||||||
equity in earnings of investment in limited liability partnership | -304,000 | |||||||||||
compensation expense in the form of common stock used to match defined contribution plan 1165 | ||||||||||||
other than temporary impairments | ||||||||||||
loan production: | ||||||||||||
maturity of term note | -15,000,000 | |||||||||||
repurchase of treasury stock | ||||||||||||
dividend paid on common and preferred stock | -4,600,000 | |||||||||||
net increase in securities purchased under agreements to resell | ||||||||||||
level 1 | ||||||||||||
level 2 | ||||||||||||
level 3 | ||||||||||||
weighted-average assumptions: | ||||||||||||
dividend yield | 4,400 | |||||||||||
expected volatility | 31,860 | |||||||||||
risk-free interest rate | 4,330 | |||||||||||
expected life | 8,500 | |||||||||||
equity in earnings of investment in limited partnership | ||||||||||||
net decrease in time deposits with other banks | ||||||||||||
purchase of treasury stocks | ||||||||||||
equity in (earnings) losses of investment in limited liability partnership | ||||||||||||
repurchase of treasury stocks | ||||||||||||
dividend paid in common and preferred stock | -4,628,000 | |||||||||||
securities and loans purchased but not yet received | 40,067,000 | 1,233,000 | ||||||||||
equity in losses (earnings) of investment in limited liability partnership | 892,000 | |||||||||||
amortization of premiums, net of accretion of discounts on investment securities | -359,000 | |||||||||||
net decrease (increase) in time deposits with other banks | ||||||||||||
equity options and put options | ||||||||||||
dividends paid on common and preferred stocks | ||||||||||||
cash and cash equivalents include: | ||||||||||||
investment securities available for sale transferred to held to maturity | ||||||||||||
common stocks used to match defined contribution plan 1165 | 92,000 | |||||||||||
accrued dividend payable | 3,448,000 | |||||||||||
other comprehensive loss for the period | -1,817,000 | |||||||||||
stock options expense | ||||||||||||
total adjustments | ||||||||||||
net increase in time deposits with other banks | ||||||||||||
purchases of equity options | ||||||||||||
common stock purchased | ||||||||||||
investment securities available-for-sale transferred to held-to-maturity | ||||||||||||
other comprehensive income for the period | ||||||||||||
net decrease (increase) in time deposits with other banks purchases of: | ||||||||||||
purchases of equity options and put options | ||||||||||||
maturities and redemption of: | ||||||||||||
premises and fixed assets | ||||||||||||
other real estate owned | ||||||||||||
issuance of subordinated capital notes | ||||||||||||
other comprehensive income for the year | ||||||||||||
stock dividend paid from treasury stock | ||||||||||||
amortization of deferred loan origination fees and costs | ||||||||||||
amortization of premiums and accretion of discounts on investment securities | ||||||||||||
derivatives activities | ||||||||||||
hedged securities available-for-sale | ||||||||||||
proceeds from sale of loans | ||||||||||||
net purchases of derivatives instruments | ||||||||||||
proceeds from sale of: | ||||||||||||
foreclosure real estate | ||||||||||||
contribution to statutory trust ii | ||||||||||||
net increase in cash and cash equivalents | ||||||||||||
short term investments | ||||||||||||
investment securities available-for-sale transferred to held-to-maturtity | ||||||||||||
securities and loans sold but not yet delivered | ||||||||||||
stock dividend paid | ||||||||||||
net purchases of equity options | ||||||||||||
real estate loans securitized into mortgage-backed securities | ||||||||||||
stock dividend | ||||||||||||
capital expenditures | ||||||||||||
stock dividend paid from treasury stock in 2004 and stock split effected in the form of a dividend in 2003 | ||||||||||||
net (purchases)/redemption of equity options | ||||||||||||
proceeds from sale of investment securities available-for-sale | ||||||||||||
demand, saving and time (including ira accounts) deposits | ||||||||||||
repayments of: | ||||||||||||
term notes | ||||||||||||
issuance of trust redeemable preferred securities | ||||||||||||
stock purchased | ||||||||||||
cancellation of stock options | ||||||||||||
origination of loans held-for-sale | ||||||||||||
purchases of investment securities available-for-sale | ||||||||||||
purchases of fhlb stock | ||||||||||||
net purchases/redemption of equity options | ||||||||||||
redemption of fhlb stock | ||||||||||||
proceeds from sales of investment securities available-for-sale | ||||||||||||
proceeds from advances and borrowings from fhlb | ||||||||||||
repayment of advances and borrowings from fhlb | ||||||||||||
repayment of term notes | ||||||||||||
proceeds for issuance of subordinated capital notes | ||||||||||||
proceeds from exercise of stock options | ||||||||||||
cash and equivalents include: | ||||||||||||
stock split effected in the form of a dividend | ||||||||||||
net cash provided (used) by operating activities | ||||||||||||
origination and purchase of loans excluding loans held-for-sale | ||||||||||||
aquisitions of foreclosed real estates | ||||||||||||
repayments of advances and borrowings from fhlb | ||||||||||||
repayments of term notes | ||||||||||||
deferred tax provision | ||||||||||||
gain on sale of securities available-for-sale | ||||||||||||
gain on sale of loans | ||||||||||||
net income on derivatives activities | ||||||||||||
maturities and redemptions of investment securities held-to-maturity | ||||||||||||
proceeds from sales of consumer loans and leases portfolio | ||||||||||||
origination and purchase of loans | ||||||||||||
other decrease | ||||||||||||
advances and borrowings from fhlb | ||||||||||||
net proceeds from issuance of subordinated capital notes |
We provide you with 20 years of cash flow statements for OFG Bancorp stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of OFG Bancorp stock. Explore the full financial landscape of OFG Bancorp stock with our expertly curated income statements.
The information provided in this report about OFG Bancorp stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.